Published in Nucleic Acids Res on October 11, 2007
Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet (2010) 10.71
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res (2010) 6.03
Linking genes to literature: text mining, information extraction, and retrieval applications for biology. Genome Biol (2008) 4.36
The Molecular Biology Database Collection: 2008 update. Nucleic Acids Res (2007) 2.46
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell (2012) 1.75
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res (2011) 1.63
Overview of the ID, EPI and REL tasks of BioNLP Shared Task 2011. BMC Bioinformatics (2012) 1.62
CCancer: a bird's eye view on gene lists reported in cancer-related studies. Nucleic Acids Res (2010) 1.62
DNA methylation of cancer genome. Birth Defects Res C Embryo Today (2009) 1.39
Large-scale event extraction from literature with multi-level gene normalization. PLoS One (2013) 1.30
HHMD: the human histone modification database. Nucleic Acids Res (2009) 1.27
NGSmethDB: a database for next-generation sequencing single-cytosine-resolution DNA methylation data. Nucleic Acids Res (2010) 1.27
DiseaseMeth: a human disease methylation database. Nucleic Acids Res (2011) 1.22
MethHC: a database of DNA methylation and gene expression in human cancer. Nucleic Acids Res (2014) 1.17
Identification of new differentially methylated genes that have potential functional consequences in prostate cancer. PLoS One (2012) 1.15
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics. Genome Med (2010) 1.14
CCDB: a curated database of genes involved in cervix cancer. Nucleic Acids Res (2010) 1.09
Genomic Rearrangements of PTEN in Prostate Cancer. Front Oncol (2013) 1.07
miRBase Tracker: keeping track of microRNA annotation changes. Database (Oxford) (2014) 1.06
MethylomeDB: a database of DNA methylation profiles of the brain. Nucleic Acids Res (2011) 1.06
Event extraction for DNA methylation. J Biomed Semantics (2011) 1.04
MeInfoText 2.0: gene methylation and cancer relation extraction from biomedical literature. BMC Bioinformatics (2011) 0.97
Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res (2015) 0.96
The first step in the development of Text Mining technology for Cancer Risk Assessment: identifying and organizing scientific evidence in risk assessment literature. BMC Bioinformatics (2009) 0.95
Epstein-Barr virus-induced epigenetic alterations following transient infection. Int J Cancer (2012) 0.92
Epigenomics and ovarian carcinoma. Biomark Med (2010) 0.91
Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Med Genomics (2008) 0.91
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia. Epigenetics (2010) 0.91
DigSee: Disease gene search engine with evidence sentences (version cancer). Nucleic Acids Res (2013) 0.90
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy. Genome Med (2009) 0.89
Prioritizing cancer-related genes with aberrant methylation based on a weighted protein-protein interaction network. BMC Syst Biol (2011) 0.87
Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data. Expert Opin Med Diagn (2013) 0.86
NGSmethDB: an updated genome resource for high quality, single-cytosine resolution methylomes. Nucleic Acids Res (2013) 0.86
MethBank: a database integrating next-generation sequencing single-base-resolution DNA methylation programming data. Nucleic Acids Res (2014) 0.85
Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels. PLoS One (2013) 0.85
Computational Epigenetics: the new scientific paradigm. Bioinformation (2010) 0.84
T-HOD: a literature-based candidate gene database for hypertension, obesity and diabetes. Database (Oxford) (2013) 0.83
DNA Methylation at the Novel CpG Sites in the Promoter of MED15/PCQAP Gene as a Biomarker for Head and Neck Cancers. Biomark Insights (2014) 0.83
Identification of histone modifications in biomedical text for supporting epigenomic research. BMC Bioinformatics (2009) 0.82
PEpiD: a prostate epigenetic database in mammals. PLoS One (2013) 0.81
SparkText: Biomedical Text Mining on Big Data Framework. PLoS One (2016) 0.80
DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death Differ (2014) 0.80
Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis. PLoS One (2013) 0.80
OncoSearch: cancer gene search engine with literature evidence. Nucleic Acids Res (2014) 0.80
Combining position weight matrices and document-term matrix for efficient extraction of associations of methylated genes and diseases from free text. PLoS One (2013) 0.79
Prediction of disease-related genes based on weighted tissue-specific networks by using DNA methylation. BMC Med Genomics (2014) 0.79
HEMD: an integrated tool of human epigenetic enzymes and chemical modulators for therapeutics. PLoS One (2012) 0.79
Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer. Sci Rep (2016) 0.78
Online tools for bioinformatics analyses in nutrition sciences. Adv Nutr (2012) 0.78
Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer. Otolaryngol Head Neck Surg (2010) 0.78
DDMGD: the database of text-mined associations between genes methylated in diseases from different species. Nucleic Acids Res (2014) 0.77
NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals. Nucleic Acids Res (2016) 0.77
Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma. J Clin Bioinforma (2011) 0.76
The identification of age-associated cancer markers by an integrative analysis of dynamic DNA methylation changes. Sci Rep (2016) 0.76
EPITRANS: a database that integrates epigenome and transcriptome data. Mol Cells (2013) 0.76
Databases and bioinformatics tools for the study of DNA repair. Mol Biol Int (2011) 0.76
DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database. Nucleic Acids Res (2016) 0.75
Human cancer databases (review). Oncol Rep (2014) 0.75
NGSmethDB 2017: enhanced methylomes and differential methylation. Nucleic Acids Res (2016) 0.75
MethSMRT: an integrative database for DNA N6-methyladenine and N4-methylcytosine generated by single-molecular real-time sequencing. Nucleic Acids Res (2016) 0.75
Identification of Cancer Related Genes Using a Comprehensive Map of Human Gene Expression. PLoS One (2016) 0.75
Integrating Epigenomics into the Understanding of Biomedical Insight. Bioinform Biol Insights (2016) 0.75
DREMECELS: A Curated Database for Base Excision and Mismatch Repair Mechanisms Associated Human Malignancies. PLoS One (2016) 0.75
AAgAtlas 1.0: a human autoantigen database. Nucleic Acids Res (2016) 0.75
Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med (2003) 18.04
GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics (1998) 15.82
DNA methylation in breast and colorectal cancers. Mod Pathol (2007) 2.88
DNA methylation and chromatin - unraveling the tangled web. Oncogene (2002) 2.79
Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol (2003) 1.65
An improved version of the DNA Methylation database (MethDB). Nucleic Acids Res (2003) 1.61
Eukaryotic DNA methylation: facts and problems. FEBS Lett (1990) 1.34
methBLAST and methPrimerDB: web-tools for PCR based methylation analysis. BMC Bioinformatics (2006) 1.18
Momentum building for human epigenome project. J Natl Cancer Inst (2006) 1.03
Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell (2012) 3.82
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet (2007) 3.39
Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell (2011) 3.07
Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell (2007) 2.62
Amplification of the pressure pulse in the upper limb in healthy, middle-aged men and women. Hypertension (2009) 2.59
Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res (2008) 2.16
Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res (2011) 2.06
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst (2006) 2.05
A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res (2012) 1.92
A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study. Eur Heart J (2010) 1.90
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J Clin Oncol (2005) 1.80
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res (2009) 1.80
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med (2008) 1.70
Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res (2008) 1.70
Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. Cancer Res (2008) 1.69
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica (2008) 1.69
Paternal age at birth is an important determinant of offspring telomere length. Hum Mol Genet (2007) 1.58
NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm. Anal Chem (2008) 1.53
Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res (2008) 1.46
Phylogenetic trees: visualizing, customizing and detecting incongruence. Bioinformatics (2005) 1.38
Deep proteome coverage based on ribosome profiling aids mass spectrometry-based protein and peptide discovery and provides evidence of alternative translation products and near-cognate translation initiation events. Mol Cell Proteomics (2013) 1.33
Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform. BMC Med Genomics (2012) 1.32
Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res (2009) 1.28
Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One (2010) 1.26
The epigenetic promise for prostate cancer diagnosis. Prostate (2011) 1.26
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res (2010) 1.24
Rationale, design, methods and baseline characteristics of the Asklepios Study. Eur J Cardiovasc Prev Rehabil (2007) 1.21
Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res (2007) 1.20
Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. J Urol (2012) 1.19
DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res (2012) 1.17
Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics. PLoS One (2011) 1.15
Quality evaluation of methyl binding domain based kits for enrichment DNA-methylation sequencing. PLoS One (2013) 1.15
Combining in silico prediction and ribosome profiling in a genome-wide search for novel putatively coding sORFs. BMC Genomics (2013) 1.12
Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat (2011) 1.11
Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet (2011) 1.11
Genome sequence of Helicobacter suis supports its role in gastric pathology. Vet Res (2011) 1.11
Aberrant silencing of cancer-related genes by CpG hypermethylation occurs independently of their spatial organization in the nucleus. Cancer Res (2010) 1.10
N-terminal proteomics and ribosome profiling provide a comprehensive view of the alternative translation initiation landscape in mice and men. Mol Cell Proteomics (2014) 1.07
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics (2012) 1.07
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One (2009) 1.06
Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res (2009) 1.06
Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes. Hum Mutat (2011) 1.05
Telomere length and cardiovascular aging: the means to the ends? Ageing Res Rev (2010) 1.04
The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer. Clin Cancer Res (2013) 1.04
A new class of ubiquitin extension proteins secreted by the dorsal pharyngeal gland in plant parasitic cyst nematodes. Mol Plant Microbe Interact (2004) 1.04
Analysing 454 amplicon resequencing experiments using the modular and database oriented Variant Identification Pipeline. BMC Bioinformatics (2010) 1.02
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers. Genome Biol (2012) 1.02
MutaDATABASE: a centralized and standardized DNA variation database. Nat Biotechnol (2011) 0.99
Telomere attrition as ageing biomarker. Anticancer Res (2005) 0.98
Detection of putative secreted proteins in the plant-parasitic nematode Heterodera schachtii. Parasitol Res (2005) 0.98
Transcriptional reprogramming by root knot and migratory nematode infection in rice. New Phytol (2012) 0.96
Transcriptional analysis through RNA sequencing of giant cells induced by Meloidogyne graminicola in rice roots. J Exp Bot (2013) 0.95
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Cancer Res (2013) 0.94
A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urol (2012) 0.94
Peptidomics coming of age: a review of contributions from a bioinformatics angle. J Proteome Res (2010) 0.93
Ionizing radiation-induced gene modulations, cytokine content changes and telomere shortening in mouse fetuses exhibiting forelimb defects. Dev Biol (2008) 0.93
Prevalence of Chlamydophila psittaci infections in a human population in contact with domestic and companion birds. J Med Microbiol (2009) 0.92
Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations. Hypertension (2008) 0.92
Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res (2008) 0.91
ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer. Clin Cancer Res (2008) 0.91
Systemic telomere length and preclinical atherosclerosis: the Asklepios Study. Eur Heart J (2009) 0.91
Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. Int J Cancer (2011) 0.91
Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis. J Pathol (2013) 0.90
Transcriptome analysis of rice mature root tissue and root tips in early development by massive parallel sequencing. J Exp Bot (2012) 0.89
Lower red blood cell counts in middle-aged subjects with shorter peripheral blood leukocyte telomere length. Aging Cell (2008) 0.88
Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years: the Asklepios Study. Arterioscler Thromb Vasc Biol (2008) 0.87
Spectral clustering in peptidomics studies helps to unravel modification profile of biologically active peptides and enhances peptide identification rate. Proteomics (2009) 0.87
Evaluation of standard and advanced preprocessing methods for the univariate analysis of blood serum 1H-NMR spectra. Anal Bioanal Chem (2010) 0.85
Diversity in protein glycosylation among insect species. PLoS One (2011) 0.85
Interaction of the tobacco lectin with histone proteins. Plant Physiol (2011) 0.85
MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids. J Clin Endocrinol Metab (2013) 0.85
Next-generation technologies and data analytical approaches for epigenomics. Environ Mol Mutagen (2013) 0.84
We are all individuals... bioinformatics in the personalized medicine era. Cell Oncol (Dordr) (2014) 0.84